Your browser doesn't support javascript.
loading
Prognosis of laparoscopic surgery for colorectal cancer in middle-aged patients.
Bao, Feng; Wu, Li-Rong; Deng, Zhi-Gang; Xiang, Chun-Hua; Shang, Jian-Ying.
Afiliação
  • Bao F; Department of General Surgery, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
  • Wu LR; Department of General Surgery, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
  • Deng ZG; Department of General Surgery, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
  • Xiang CH; Department of General Surgery, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
  • Shang JY; Department of General Surgery, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
J Minim Access Surg ; 19(2): 263-271, 2023.
Article em En | MEDLINE | ID: mdl-35915539
ABSTRACT

Background:

The prognosis of middle-aged patients with colorectal cancer (CRC) treated by laparoscopic resection (LR) is unclear. This study aimed to evaluate the survival outcomes of LR compared with open resection (OR) for middle-aged patients with CRC. Patients and

Methods:

This retrospective cohort study used the data from a database of all consecutive colorectal resections performed between January 2009 and December 2017. Propensity score matching (PSM) was performed to handle the selection bias based on age, gender, body mass index, tumour location, AJCC stage and admission year. Univariate and multivariate COX regression model was used to identify risk factors of overall survival (OS) and disease-free survival (DFS).

Results:

After PSM, 154 patients were included in each group. Compared with the OR group in the total cohort, there were better survival outcomes in the LR group for 5-year OS and 5-year DFS (both P < 0.001). These differences were observed for Stage II and III diseases and for all CRC, irrespective of location. The multivariate analysis showed that tumour ≥5 cm (hazard ratio [HR] = 1.750, 95% confidence interval [CI] 1.026-2.986, P = 0.040), Stage III (HR = 14.092, 95% CI 1.894-104.848, P = 0.010) and LR (HR = 0.300, 95% CI 0.160-0.560, P < 0.001) were independently associated with OS. Pre-operative carcinoembryonic antigen ≥5 ng/ml (HR = 3.954, 95% CI 1.363-11.473, P = 0.011), Stage III (HR = 6.206, 95% CI 1.470-26.200, P = 0.013) and LR (HR = 0.341, 95% CI 0.178-0.653, P = 0.001) were independently associated with DFS.

Conclusions:

In middle-aged patients with CRC, LR achieves better survival than OR. Complications are similar, except for less blood loss and shorter post-surgical hospital stay with LR.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Minim Access Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Minim Access Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China